Semler Scientific Faces Securities Fraud Lawsuit with Lead Plaintiff Deadline on October 28, 2025

Investors who have invested in Semler Scientific, Inc. (NASDAQ: SMLR) are in a position to take action by leading a securities fraud lawsuit before the deadline of October 28, 2025. The Rosen Law Firm initiated the lawsuit, alleging that Semler Scientific had been making false and deceptive statements in relation to a Department of Justice investigation concerning violations of the False Claims Act. Individuals who have purchased Semler Scientific securities between March 10, 2021, and April 15, 2025, may have the opportunity to receive compensation through a contingency fee arrangement without incurring any out-of-pocket expenses.

The lawsuit contends that Semler Scientific failed to disclose a significant investigation by the United States Department of Justice into potential violations of the False Claims Act while discussing these violations in a hypothetical manner. Consequently, the company’s public statements were deemed materially false and misleading during the relevant period, leading to financial losses for investors when the truth of the matter was revealed to the public.

Potential claimants have until October 28, 2025, to request the Court to designate them as lead plaintiff in the case. This deadline holds significance as being appointed as lead plaintiff is not a prerequisite to sharing in any financial recovery resulting from the lawsuit. The Rosen Law Firm advises investors to engage qualified legal representation with a proven track record of success in leadership roles.

In addition to The Rosen Law Firm’s lawsuit, other legal entities such as The Schall Law Firm and Levi & Korsinsky, LLP have also filed similar lawsuits against Semler Scientific, Inc., alleging the same set of violations and offering the same deadline for potential claimants to take action. Investors are encouraged to thoroughly review the specifics of these lawsuits and carefully assess their options before proceeding.

As the legal proceedings continue, it is important for affected parties to be aware of their rights and potential for compensation. By staying informed and seeking appropriate legal counsel, investors can navigate the complexities of securities fraud cases like the one involving Semler Scientific, Inc. Investing wisely and being vigilant about fraudulent practices in the financial markets is crucial to protecting one’s assets and ensuring fair treatment in the realm of securities trading.